New report shares details about the Influenza Vaccine market

Global Influenza Vaccine Market Overview:

Influenza is commonly known as “flu” or “seasonal flu” caused by influenza virus. The symptoms of influenza can be mild to severe ranging from fever to pneumonia. Influenza mainly affected by three type’s influenza virus, called type A, type B and type C. Influenza virus generally spread through the air by coughing and sneezing or touching contaminated surfaces by a virus. Influenza can be diagnosed by testing throat, sputum and nose. Numbers of rapid tests are available for detecting influenza virus. Influenza can be treated with antiviral drugs or prevented by administering influenza vaccine and several other fluid management methods. Influenza virus spreads around the world in yearly outbreaks that result in millions of severe illness and thousands of deaths across the world. WHO every year predicts few strains which are expected to circulate in following year, that allows pharmaceutical companies to develop influenza vaccine against these stains.

Recommendation by WHO and U.S’s Centers for Disease Control and Prevention (CDC) for yearly vaccination in high-risk group patients, cost of effectiveness of seasonal influenza vaccine in different age groups and settings expected to drive the market for influenza vaccine over the forecast period. Moreover reduced healthcare burden due to influenza vaccination expected to propel the market for influenza vaccine. For instance, in 2015-2016 influenza seasons, CDC estimates that influenza vaccination prevented approximately 5.1 million influenza illnesses, 2.5 million influenza-associated medical visits, and 71,000 influenza-associated hospitalizations. However, Influenza vaccine made in a year may not be effective in following year owing to evolving nature of influenza virus, in healthy individual influenza vaccine is modestly effective, sometimes new strain or overlooked strain become prevalent in that season, and product recalls which may hamper the uptake and growth influenza vaccine market.

Get Free sample PDF Brochure of Market Study @ http://www.planetmarketreports.com/report-sample/influenza-vaccines-market-60

Influenza Vaccines market has been segmented on the basis of vaccine type, strain type, formulation type, end user, and region

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales volume, revenue value, market share and growth rate of Influenza Vaccines in these regions, from 2012 to 2022 forecast.

United States Influenza Vaccines market competition by top manufacturers/players, with Influenza Vaccines sales volume, price, revenue Million USD and market share for each manufacturer/player; the top players including

Sanofi Pasteur
GSK
Seqirus
AstraZeneca
Protein Science Corporation...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Trivalent Influenza Vaccines
Quadrivalent Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospital
Clinic
Other

Players in influenza vaccine market focusing on developing effective vaccine i.e.quadrivalent against influenza virus and eyeing on expanding geographic presence to increase the market revenue for influenza vaccine products. For Instance, in June 2016, Sanofi received a positive end of a procedure from the German which helps in getting market authorization for VaxigripTetra, a quadrivalent vaccine against influenza. Several leading players in influenza vaccine market shipping the vaccine to U.S. market to meet seasonal demand in the country. Securing government tenders has become essential for influenza vaccine manufacturers to gain larger market share and helps in sustaining the business. For instance, in 2015, Sinovac Biotech Ltd. received the tender award from Beijing government to supply seasonal influenza vaccine.

Influenza Vaccines market has been segmented into five regions Viz. North Americas, Europe, Asia Pacific, Latin America and the Middle East and Africa. Each year, there are two seasons of influenza because of northern and southern hemispheres have winter in different times. An occurrence of influenza infections high in developing countries than developed counters which make the market lucrative for players in developing countries. However, Influenza vaccine market in North America expected to witness significant growth owing U.S.’s yearly vaccination programme. In Europe influenza vaccine limited to the high-risk groups rather than blanket vaccination programmes which market to grow at moderate growth rate. Asia Pacific market expected to grow at significant CAGR owing to increasing affordability, larger and subsidized immunization programs in several countries in the Asia region.

In Jan 2016, CSL Limited acquired Novartis AG’s influenza vaccine business in Germany, as a part of global influenza vaccine
In June 2016, Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has recommended not to use AstraZeneca’s FluMist Quadrivalent Influenza vaccine in any settings owing to lack of statistically significant effectiveness in children
Report Outline:

The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments, and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

About Us:-

Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

Contact US:-

Name: Ronald James

Email-Id: ronald.james@planetmarketreports.com

US : +1-716-2260907

UK : +447441952057

Organization: Planet Market Reports

This release was published on openPR.